Corphena Solution
NDC Package 73684-300-08
Package Information
Corphena (dexchlorpheniramine maleate) solution is dexchlorpheniramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. This formulation utilizes a solution delivery system. Marketed by Blucrest Pharmaceuticals Llc, this product is identified by NDC 73684-300 and is authorized under FDA application ANDA202520.
Identification & Billing
- RxCUI: 2183907 - dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution
- RxCUI: 2183907 - dexchlorpheniramine maleate 0.4 MG/ML Oral Solution
- RxCUI: 2183907 - dexchlorpheniramine 2 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 73684 - Blucrest Pharmaceuticals Llc
- 73684-300 - Corphena
- 73684-300-08 - 237 mL in 1 BOTTLE, PLASTIC
- 73684-300 - Corphena
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 73684-300-08 identifies a specific commercial package of 237 ml in 1 bottle, plastic of Corphena, a human prescription drug labeled by Blucrest Pharmaceuticals Llc. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This solution is formulated for oral use and contains dexchlorpheniramine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blucrest Pharmaceuticals Llc on October 22, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Dexchlorpheniramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms may include rash, watery eyes, itchy eyes/nose/throat/skin, cough, runny nose, and sneezing. This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. It also blocks another natural substance made by your body (acetylcholine). Blocking acetylcholine helps lessen symptoms such as watery eyes and runny nose. Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medications that contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How is this Blucrest Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 73684030008. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.